A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal.
The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
There currently are no established screening strategies for ovarian cancer. The disease often causes no specific symptoms and is difficult to detect in the early stages when it is most responsive to treatment. Therefore, ovarian cancer is highly lethal because most women have advanced disease when they are diagnosed.
Karen Lu, MD, of The University of Texas MD Anderson Cancer Center in Houston, led a team that tested the potential of a two-stage ovarian cancer screening strategy that incorporates changes in a blood protein called CA125, which is a known tumor marker. In their 11-year study, 4051 post- menopausal women initially underwent an annual CA125 blood test. Based on a calculation called the “Risk of Ovarian Cancer Algorithm,” women were divided into three groups: those who should receive another CA125 test one year later (low risk), those who should receive a repeat CA125 in three months (intermediate risk), and those who should receive a transvaginal ultrasound and be referred to a gynecologic oncologist (high risk).
An average of 5.8 percent of women were found to be of intermediate risk each year, meaning that they should receive a CA125 test in three months. The average annual referral rate to transvaginal ultrasound and review by a gynecologic oncologist was 0.9 percent. Ten women underwent surgery based on their ultrasound exams, with four having invasive ovarian cancers, two having ovarian tumors of low malignant potential, one having endometrial cancer, and three having benign ovarian tumors. This equates to a positive predictive value of 40 percent for detecting invasive ovarian cancer. The specificity of the testing strategy was 99.9 percent, meaning that only 0.1 percent of patients without cancer would be falsely identified as having the disease. Importantly, all of the ovarian cancers were early stage.
The Latest on: Ovarian cancer
Birth control: Does it affect my cancer risk?
on April 22, 2018 at 4:30 pm
Decreased risk for some cancers Taking birth control pills decreases your risk for ovarian, uterine and colorectal cancers. The protective effect lasts up to 15 years for uterine cancer after you stop using birth control and up to 30 years for ovarian ... […]
Personalized vaccine helps patients fight ovarian cancer
on April 22, 2018 at 4:30 am
In early research that involved marshaling the body’s own immune system, a personalized vaccine helped patients with ovarian cancer mount a stronger defense against their tumors than standard therapy and substantially improved their survival rate. […]
College softball: LSU, Texas A&M team up to show support for Mississippi State's Alex Wilcox, ovarian cancer awareness
on April 21, 2018 at 2:48 pm
In softball, no matter the team or allegiance, no one ever stands alone. Saturday afternoon, LSU and Texas A&M proudly displayed that for Mississippi State freshman Alex Wilcox. Tonight, we're playing for something bigger than ourselves! @Alex_wilcox8 ... […]
Breast, Ovarian Cancer risk results now available online
on April 20, 2018 at 3:18 pm
For years, at-home genetic tests have been popular. Some - like 23andMe - even give clients the ability to see genetic risk factors for diseases like Alzheimer's or Macular Degeneration. Despite that, the U.S. Food & Drug Administration banned the release ... […]
Promising Personalized Ovarian Cancer Vaccine Induces Immune Responses
on April 19, 2018 at 8:44 am
A personalized cancer vaccine using autologous dendritic cells was well tolerated and was capable of inducing antitumor T-cell immunity in patients with recurrent ovarian cancer, according to a new small trial. “One…form of immunotherapy that can ... […]
Hattiesburg's Downtown Crawfish Jam dedicated to longtime volunteer with ovarian cancer
on April 19, 2018 at 8:20 am
Hattiesburg's Downtown Crawfish Jam dedicated to longtime volunteer with ovarian cancer The 20th annual Downtown Crawfish Jam will feature an all-female lineup and dedicated to a longtime volunteer recently diagnosed with ovarian cancer. Check out this ... […]
Europe Ovarian Cancer Therapeutics Market Growth, Trends, And Forecasts (2016–2021)
on April 19, 2018 at 1:07 am
A woman's danger of having ovarian cancer at some point in her life is 1 in 78. Her lifetime danger of demise from ovarian cancer is set 1 in 108. View sample and decide: https://www.marketdataforecast.com/market-reports/europe-ovarian-cancer-therapeutics ... […]
Geaux Teal Ovarian Cancer Walk happening Saturday
on April 18, 2018 at 3:25 pm
The 6th annual Geaux Teal Ovarian Cancer walk is scheduled for Saturday, April 21 at the LSU softball complex at Tiger Park in Baton Rouge. Geaux Teal is an organization working to raise awareness about ovarian cancer and teach women of all ages about the ... […]
Diagnosed with ovarian cancer a year apart, friends walk for research funds
on April 18, 2018 at 11:11 am
Brooke Nicklas and Michelle McGee first became friends when their sons were in first grade together. They couldn't have guessed the uncanny parallels their lives would take nearly 15 years later, including an ovarian cancer diagnosis barely a year apart. […]
2018 Ovarian Cancer Pipeline Highlights - ResearchAndMarkets.com
on April 17, 2018 at 3:57 pm
DUBLIN--(BUSINESS WIRE)--Apr 17, 2018--The "Ovarian Cancer Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering. Ovarian Cancer Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in ... […]
via Google News and Bing News